Interleukin enhancer-binding factor 3 (ILF3) (AA 652-702) antibody
Quick Overview for Interleukin enhancer-binding factor 3 (ILF3) (AA 652-702) antibody (ABIN7453923)
Target
See all Interleukin enhancer-binding factor 3 (ILF3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 652-702
-
Purpose
- Rabbit anti-NF90 Antibody, Affinity Purified
-
Predicted Reactivity
- Monkey
-
Purification
- Affinity Purified
-
Immunogen
- Between AA 652 and 702
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IHC: 1:2,000 - 1:10,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Expiry Date
- 12 months
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Alternative Name
- NF90
-
Background
- Background: NFAR (nuclear factor associated with dsRNA) exists as two major protein species of 90 kDa (NFAR-1 or NF90) and 110 kDa (NFAR-2 or NF110) in the cell. NF90 and NF110 arise from a single gene named interleukin enhancer binding factor (ILF3) gene which resides on chromosome 19p13 and are generated through alternative splicing events. NF90 is a dsRNA binding protein that stabilizes mRNAs and regulates transcription. NF90 is a subunit of the nuclear factor of activated T-cells (NFAT) transcription factor that is required for T-cell expression of interleukin 2. The NF110 isoform is restricted to the nucleus and its function may be unrelated to NF90.
-
Gene ID
- 3609
-
NCBI Accession
- NP_004507
-
UniProt
- Q12906
-
Pathways
- M Phase
Target
-